NIH-funded research R01 grant

New technology for delivering RNA to the brain

Official title: Precision RNA delivery technology to unlock new potentials in CNS biology

Funded at Texas A&m Agrilife Research · NIH-11029063 · Data updated 2026-11-12

This study is working on a new way to deliver RNA directly to the brain and nervous system, aiming to target the right cells safely and effectively, which could help improve treatments for conditions affecting these areas.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas A&m Agrilife Research
NIH-funded
Lab location1 site (College Station, UNITED STATES)
Project startJune 1, 2025
Project endFebruary 28, 2029
Funding year2025
Award (this year)$337,088
NIH project number1R01GM157259-01
Project IDNIH-11029063 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would be individuals with neurological disorders that could benefit from targeted RNA therapies.

Less likely to help

Patients with conditions unrelated to the central nervous system may not receive any benefit from this research.

What this research studies

This research focuses on developing a new platform for delivering RNA specifically to the central nervous system (CNS). It aims to create a system that can efficiently target specific cells while minimizing any harm to them. The approach involves engineering special capsids that can release RNA once inside the cells and modifying their surfaces to ensure they enter the right cells. The effectiveness of this technology will be tested in living organisms to ensure it works better than existing methods without causing cellular stress.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for neurological conditions by allowing precise control over gene expression in the brain.

How similar studies have gone: Previous research has shown promise in RNA delivery technologies, but this approach aims to address specific limitations that have not yet been fully explored.

Where this research is happening

  • Texas A&m Agrilife Research
    College Station, United States
    Active

Researchers

  • Principal investigator: Pellois, Jean-Philippe — Texas A&m Agrilife Research
  • Study coordinator: Pellois, Jean-Philippe

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.